Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date06 Oct 2003 |
Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date01 Apr 1998 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date26 Feb 1982 |
100 Clinical Results associated with Nikko Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Nikko Pharmaceutical Co., Ltd.
100 Deals associated with Nikko Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Nikko Pharmaceutical Co., Ltd.